Our story started in 2008 when Prof. Jouko Yliruusi and Prof. Edward Hæggström first combined their respective expertise in pharmaceutical chemistry and physics. This extraordinary collaboration produced a novel particle engineering technology with the ability to transform the pharmaceutical industry.
They discovered the Controlled Expansion of Supercritical Solutions (CESS®) process in 2012 at the University of Helsinki and Nanoform was founded in 2015. Since then, Nanoform has expanded rapidly, transforming into a company with global ambition. Our best-in-class nanoformingTM services will help the global pharmaceutical industry double its annual new medicines output. We are proud to be a Finnish success story with an international outlook.
innovation enables your
drugs to reach their
Nanoform core values
We are a pioneering company driven by a passion for innovation and a
commitment to solving our partners’ problems.
Our mission is to support pharma companies as they develop life-changing medicines, by overcoming drug development & delivery challenges.
We will help the global pharma industry double the amount of lead compounds progressing into clinic.
We will always push scientific boundaries to find ground-breaking solutions to drug development problems.
We pride ourselves on being a high-quality service provider that consistently adds value to your company.
We are an engaged partner that works side-by-side with you to find tailored solutions to individual problems.
We provide timely and responsive communication at every stage of the project.
We value the opinions and insights of our team and believe that mutual respect is the foundation of a happy and productive work environment.
Introducing our team
Nanoform has attracted talented individuals from across the globe. Our unique approach to drug particle engineering has brought together an ambitious team of scientists with world-renowned experts in pharmaceutical business development. Every member of our team is dedicated to accelerating your compound to market.
of our staff have PhDs
Our latest success story
Our leading-edge technology has proven successful. Read our most recent good news.